Ligustrazine hydrochloride CAS 76494-51-4

Tetramethylpyrazine Hydrochloride

Flash Point: 128-130°C/200mm

Moisture: ————

Purity:————

Density: ————

Solubility: Dissolving in the water.

1. Anti-platelet aggregation, arteriectasia, is used for treat of Occlusive Cerebrovascular Disease.  2. Ligustrazine have the effects of dilatation of coronary artery, antihypertensive, improve the capacity of myocardial hypoxia, inhibit platelet aggregation, stimulation of respiratory center, relaxation of trachobronchial smoofh muscle, come up with the high ventilation function, prevent forming immune complex, stop bacteria growth, promote inflammatory absorption, strengthen capillary compactness, reduce blood viscosity, improve the cycle, increase the blood suppliment of the viscera important organs and other functions. Anticoagulant, With the depolymerization effect for the aggregation of platelet. Arteriectasia, improve microcirculation and increase cerebral blood flow, to make the antithrombotic and dissolving thrombus.

We manufacture pharmaceutical inter-mediate conforming to --GMP (Good Manufacturing Practices) standards.

Our efficient and systematic manufacturing facility and effective supply chain system ensures quickly send within 30 days of confirmation of the order.

We offer products with customized packing and various suture-needle combination as required by the customer.

We manufacture and supply 56-95-1, 3697-42-5, 18472-51-0, 20880-92-6, 1124-11-4, 76494-51-4, 118-29-6 as per the customer requirements.